Medtronic plc (ETR:2M6)

Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of EUR 116.45 billion. The enterprise value is 134.51 billion.

Market Cap	116.45B
Enterprise Value	134.51B

Important Dates

The last earnings date was Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	Sep 26, 2025

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	-1.73%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.98%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 28.43 and the forward PE ratio is 17.93.

PE Ratio	28.43
Forward PE	17.93
PS Ratio	3.90
PB Ratio	2.77
P/TBV Ratio	n/a
P/FCF Ratio	26.02
P/OCF Ratio	19.04
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.80, with an EV/FCF ratio of 30.05.

EV / Earnings	32.84
EV / Sales	4.49
EV / EBITDA	15.80
EV / EBIT	22.94
EV / FCF	30.05

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.60.

Current Ratio	2.42
Quick Ratio	1.48
Debt / Equity	0.60
Debt / EBITDA	2.95
Debt / FCF	5.59
Interest Coverage	9.57

Financial Efficiency

Return on equity (ROE) is 9.82% and return on invested capital (ROIC) is 5.48%.

Return on Equity (ROE)	9.82%
Return on Assets (ROA)	4.68%
Return on Invested Capital (ROIC)	5.48%
Return on Capital Employed (ROCE)	8.35%
Revenue Per Employee	314,542
Profits Per Employee	43,112
Employee Count	95,000
Asset Turnover	0.38
Inventory Turnover	2.06

Taxes

In the past 12 months, Medtronic has paid 778.89 million in taxes.

Income Tax	778.89M
Effective Tax Rate	15.90%

Stock Price Statistics

The stock price has increased by +10.37% in the last 52 weeks. The beta is 0.74, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+10.37%
50-Day Moving Average	82.55
200-Day Moving Average	79.32
Relative Strength Index (RSI)	71.30
Average Volume (20 Days)	2,141

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.87

Income Statement

In the last 12 months, Medtronic had revenue of EUR 29.88 billion and earned 4.10 billion in profits. Earnings per share was 3.17.

Revenue	29.88B
Gross Profit	19.60B
Operating Income	5.84B
Pretax Income	4.90B
Net Income	4.10B
EBITDA	8.23B
EBIT	5.84B
Earnings Per Share (EPS)	3.17

Balance Sheet

The company has 7.16 billion in cash and 25.02 billion in debt, giving a net cash position of -17.82 billion.

Cash & Cash Equivalents	7.16B
Total Debt	25.02B
Net Cash	-17.82B
Net Cash Per Share	n/a
Equity (Book Value)	42.00B
Book Value Per Share	32.63
Working Capital	12.09B

Cash Flow

In the last 12 months, operating cash flow was 6.12 billion and capital expenditures -1.64 billion, giving a free cash flow of 4.48 billion.

Operating Cash Flow	6.12B
Capital Expenditures	-1.64B
Free Cash Flow	4.48B
FCF Per Share	n/a

Margins

Gross margin is 65.58%, with operating and profit margins of 19.56% and 13.71%.

Gross Margin	65.58%
Operating Margin	19.56%
Pretax Margin	16.39%
Profit Margin	13.71%
EBITDA Margin	27.54%
EBIT Margin	19.56%
FCF Margin	14.98%

Dividends & Yields

This stock pays an annual dividend of 2.54, which amounts to a dividend yield of 2.80%.

Dividend Per Share	2.54
Dividend Yield	2.80%
Dividend Growth (YoY)	-0.47%
Years of Dividend Growth	1
Payout Ratio	75.86%
Buyback Yield	1.73%
Shareholder Yield	4.53%
Earnings Yield	3.52%
FCF Yield	3.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.91 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.91
Piotroski F-Score	7